Administration of dapagliflozin to a rotenone-induced PD rat model attenuated motor dysfunction, documented by the open-field and rotarod, with concurrent diminished α-synuclein expression, improved dopamine secretion, alleviated oxidative stress, and decreased dopaminergic neuronal loss [181]. Here, SNCA is linked to Parkinson disease.